By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Angiotensin receptor blockers > Losartan > Losartan Dosage
Angiotensin receptor blockers
https://themeditary.com/dosage-information/losartan-dosage-6092.html

Losartan Dosage

Drug Detail:Losartan (Losartan [ loe-sar-tan ])

Drug Class: Angiotensin receptor blockers

Contents
Uses Warnings Before Taking Dosage Side effects Interactions FAQ

Usual Adult Dose for Diabetic Nephropathy

Initial dose: 50 mg orally once a day
Maximum dose: 100 mg orally once a day

Comments:

  • If hypertensive patients with left ventricular hypertrophy or type 2 diabetic nephropathy patients require titration from initial dose, increase to 100 mg orally once a day.
  • Antihypertension is substantially present within 1 week but in some studies the maximal effect occurred in 3 to 6 weeks.

Uses:
  • Treatment of hypertension.
  • To reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.
  • Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (urinary albumin to creatinine ratio 300 mg/g or greater) in patients with type 2 diabetes and a history of hypertension.

Usual Adult Dose for Hypertension

Initial dose: 50 mg orally once a day
Maximum dose: 100 mg orally once a day

Comments:

  • If hypertensive patients with left ventricular hypertrophy or type 2 diabetic nephropathy patients require titration from initial dose, increase to 100 mg orally once a day.
  • Antihypertension is substantially present within 1 week but in some studies the maximal effect occurred in 3 to 6 weeks.

Uses:
  • Treatment of hypertension.
  • To reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.
  • Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (urinary albumin to creatinine ratio 300 mg/g or greater) in patients with type 2 diabetes and a history of hypertension.

Usual Pediatric Dose for Hypertension

6 Years or Older:
Initial dose: 0.7 mg/kg orally once a day (up to 50 mg total)

Comments:

  • May be given as a tablet or suspension.
  • Doses above 1.4 mg/kg (or 100 mg) daily have not been studied in pediatric patients.

Renal Dose Adjustments

Adult:
No adjustment recommended

Pediatric:
GFR less than 30 mL/min/1.73 m2: Not recommended

If a clinically significant decrease in renal function develops during therapy: Consider withholding or discontinuing this drug.

Liver Dose Adjustments

Mild to moderate liver dysfunction: Initial dose: 25 mg orally once a day
Severe liver dysfunction: Data not available

Dose Adjustments

Patients with possible intravascular volume depletion:

  • Initial dose: 25 mg orally once a day

Precautions

US BOXED WARNING:

  • FETAL TOXICITY: If pregnancy is detected, discontinue this drug as soon as possible. Drugs that act directly on the renin angiotensin system (RAS) can cause injury and death to the developing fetus.

Safety and efficacy have not been established in patients younger than 6 years.

Consult WARNINGS section for additional precautions.

Dialysis

No adjustment recommended

Other Comments

Administration advice: Pediatric dose may be administered as a tablet or suspension.

Storage requirements: Prepared suspension should be refrigerated at 2 to 8C (36 to 46F) and can be stored for up to 4 weeks.

Reconstitution/preparation techniques: The manufacturer product information should be consulted.

Monitoring:

  • Monitor renal function periodically.
  • Closely monitor potassium and CrCl, especially in patients with heart failure or CrCl 30 to 50 mL/min.

Patient advice:
  • Females of childbearing age should be informed of the consequences of exposure to this drug during pregnancy; ask these patients to report pregnancies as soon as possible.
  • Advise patients against using potassium-sparing diuretics, potassium supplements or potassium-containing salt substitutes without consulting their physician.

Frequently asked questions

  • Does Losartan block the receptor used by the Coronavirus?
  • Can you eat bananas when taking losartan?
  • Losartan vs Valsartan - What's the difference between them?
  • Does losartan cause rapid heart rate, irregular heartbeat or low blood pressure?
  • Are losartan and losartan potassium the same or different drugs?
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by